Cerevel Therapeutics Holdings Chief Corporate Affairs Officer Kathleen MA receives $3.7M in 2020
Cerevel Therapeutics Holdings reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Cerevel Therapeutics Holdings reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, five executives at Cerevel Therapeutics Holdings received on average a compensation package of $2.7M, a 49% decrease compared to previous year.
Average pay of disclosed executives at Cerevel Therapeutics Holdings
Kathleen Tregoning, M.A, Chief Corporate Affairs Officer, received $3.7M in total. 89% of MA's compensation, or $3.3M, was in option awards. MA also received $100K in bonus, $114K in non-equity incentive plan, as well as $193K in salary.
Bryan Phillips, Chief Legal Officer, received a compensation package of $3.4M. 74% of the compensation package, or $2.5M, was in option awards.
N. Anthony Coles, Chief Executive Officer, earned $2.7M in 2020, a 74% decrease compared to previous year.
John Renger, Chief Scientific Officer, received $1.8M in 2020, which decreases by 13% compared to 2019.
Raymond Sanchez, Chief Medical Officer, earned $1.8M in 2020, a 40% decrease compared to previous year.
Related executives
N Coles
Cerevel Therapeutics Holdings
Chief Executive Officer
John Renger
Cerevel Therapeutics Holdings
Chief Scientific Officer
Kathleen MA
Cerevel Therapeutics Holdings
Chief Corporate Affairs Officer
Bryan Phillips
Cerevel Therapeutics Holdings
Chief Legal Officer
Raymond Sanchez
Cerevel Therapeutics Holdings
Chief Medical Officer
You may also like
Source: SEC filing on April 28, 2021.